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Background: Carbon nanotubes (CNTs) are novel materials with considerable potential in many 
areas related to nanomedicine. However, a major limitation in the development of CNT-based 
therapeutic nanomaterials is a lack of reliable and reproducible data describing their chemical and 
structural composition. Knowledge of properties including purity, structural quality,   dispersion 
state, and concentration are essential before CNTs see widespread use in in vitro and in vivo 
experiments. In this work, we describe the characterization of several commercially available 
and two in-house-produced CNT samples and discuss the physicochemical profiles that will 
support their use in nanomedicine.
Methods: Eighteen single-walled and multi-walled CNT raw materials were characterized using 
established analytical techniques. Solid CNT powders were analyzed for purity and structural 
quality using thermogravimetric analysis and Raman spectroscopy. Extinction coefficients for 
each CNT sample were determined by ultraviolet-visible near infrared absorption spectroscopy. 
Standard curves for each CNT sample were generated in the 0–5 µg/mL concentration range 
for dispersions prepared in 1,2-dichlorobenzene.
Results: Raman spectroscopy and thermogravimetric analysis results demonstrated that CNT 
purity and overall quality differed substantially between samples and manufacturer sources, and 
were not always in agreement with purity levels claimed by suppliers. Absorbance values for 
individual dispersions were found to have significant variation between individual single-walled 
CNTs and multi-walled CNTs and sources supplying the same type of CNT. Significant differ-
ences (P , 0.01) in extinction coefficients were observed between and within single-walled 
CNTs (24.9–53.1 mL·cm-1·mg-1) and multi-walled CNTs (49.0–68.3 mL·cm-1·mg-1). The results 
described here suggest a considerable role for impurities and structural inhomogeneities within 
individual CNT preparations and the resulting spectroscopic properties of their dispersions.
Conclusion: Raw CNT materials require thorough analytical workup before they can be used 
as nanoexcipients. This applies especially to the determination of CNT purity, structure, and 
concentration. The results presented here clearly demonstrate that   extinction   coefficients must 
be determined for individual CNT preparations prior to their use.
Keywords: carbon nanotubes, pharmaceutical characterization, Raman spectroscopy, 
  thermogravimetric analysis, ultraviolet-visible near infrared spectroscopy
Introduction
Tailored nanomaterials have become increasingly important in the development 
of targeted medical therapies and pharmaceutical products. As a result of their 
nanoscale dimensions, the physicochemical properties for the individual molecules 
of these materials can differ considerably compared with the bulk material from 
which they are obtained. The exceptionally high surface areas associated with many 
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nanoparticles provide them with an increased capacity to 
carry combinations of active targeting agents simultane-
ously, moieties that increase plasma half-life, and structures 
to facilitate controlled drug release. Properties related to 
molecular surfaces, such as surface charge density and 
hydrophobicity, can also provide a platform for formulat-
ing delivery vehicles tailored to drugs with low solubil-
ity or difficulties with in vitro and in vivo drug stability. 
Incorporating nanomaterials, such as carbon nanotubes 
(CNTs), into pharmaceutical formulations can result in 
enhanced biodistribution and pharmacokinetic proper-
ties, increasing the efficacy of a therapeutic product and 
potentially reducing unwanted side effects.1
In the past decade, CNTs have emerged as promis-
ing and potentially versatile materials in the field of 
nanomedicine.2–5 CNTs are seamless cylinders of graphene 
sheets which, depending on the number of individual 
graphene layers, can be classified as either single-walled 
or multi-walled CNTs. A significant research effort is cur-
rently being devoted to determining the feasibility of CNTs 
for use in the development of nanomedicines.2,6,7 However, 
cross-comparison of the CNT preparations used by many 
of these research groups is impeded by a persistent absence 
of standardized protocols for evaluating CNTs as excipi-
ents. While the underlying structure of CNTs is relatively 
simple, the materials themselves can differ tremendously 
depending on the synthesis technique and purification treat-
ments used during their manufacture.8–11 The combination 
of ill-defined standardization protocols and a high degree 
of variability in manufacturing and purification procedures 
complicate the determination and design of a single set of 
CNT standards.12
In recognition of the rapidly growing field of nano-
medicine, the US Food and Drug Administration (FDA) 
formed a Nanotechnology Task Force in 2006. The central 
aim of this task force was the determination of critical 
regulatory issues related to the approval of pharmaceuti-
cal products containing nanomaterials such as CNTs.13,14 
While no additional guidelines or regulatory require-
ments have been released for formulations containing 
nanoparticles, thorough physicochemical characterization 
of all constituents in these products is essential for FDA 
approval.15–17 Basic physicochemical characterization 
includes, but is not limited to, characterization of struc-
ture, composition, quality, purity, and reproducibility of 
nanoparticle synthesis.
In this work, we describe the characterization of several 
commercially sourced and in-house-produced single-
walled CNT and multi-walled CNT bulk samples with 
respect to their structure, purity, and solution properties 
using   thermogravimetric analysis (TGA), Raman spec-
troscopy, and ultraviolet-visible near infrared absorption 
spectroscopy. We observed that the overall quality of 
CNTs, including their reported purity, homogeneity, and 
solubility, differs significantly among the samples tested. 
These results clearly demonstrate that the physicochemi-
cal characteristics of CNTs, in particular their absorption 
properties, differ in regard to the CNT type and source, 
and even vary within individual samples. The progression 
of CNT-based nanomedicine formulations into a clinical 
setting will be dependent on enhanced characterization of 
their physicochemical and toxic properties as it relates to 
their use as bulk excipients.18–20
Materials and methods
Materials
1,2-dichlorobenzene (DCB), Chromasolv® 99% purity grade, 
was purchased from Sigma-Aldrich (Oakville, ON, Canada). 
  Single-walled CNTs and multi-walled CNTs with a manufac-
turer reported purity of .95% were purchased from several 
suppliers, ie, NanoIntegris Inc (Skokie, IL), Cheap Tubes Inc 
(Brattleboro, VT), NanoLab Inc (Newton, MA), and Unidym 
Inc (Sunnyvale, CA). See Table 1 for a list and nomenclature 
of all 18 CNT samples and their properties as provided by 
the suppliers.
Synthesis of multi-walled CNT  
samples 11 and 12
In-house multi-walled CNTs (denoted MWNT 11 and 
MWNT 12) were synthesized via a catalytic chemical vapor 
deposition procedure in an SSP-354 synthesizer (Nanotech 
Innovations, Betatek Inc, Toronto, ON, Canada) under inert gas 
(argon 1 L/minute) conditions. A precursor CNT solution (Nan-
otech Innovations) was injected at a flow rate of 7.5 mL/hour, 
and the product was deposited onto a quartz cylindrical pro-
cess tube. The process tube had two heating zones, ie, zone 1, 
set to 225°C, and zone 2, set to 700°C. Upon cooling of 
the process tube, the deposited multi-walled CNT material 
was collected from zone 2 of the tube by careful scraping. 
A vial (25 mL) of precursor solution yielded about 200 mg 
of multi-walled CNTs. This synthesized CNT material was 
used without any further purification.
Thermogravimetric analysis
TGA of CNT powders was obtained in duplicate or trip-
licate using a Q500 TGA instrument (TA Instruments, 
Grimsby, ON, Canada). Sample masses analyzed ranged 
between 1 mg and 2 mg of CNT, as determined by the 
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TGA instrument. Platinum pans with samples were first 
equilibrated to 30°C, and then heated to 800°C at a rate of 
10°C/minute. An   oxidizing environment was maintained 
inside the chamber by the introduction of air at a flow rate 
of 25 mL/minute.
raman spectroscopy
CNTs were characterized in their dry state using a Senterra 
Dispersive Raman Spectrometer (Bruker Optics, Milton, ON, 
Canada), with a 532 nm Nd:YAg laser at room temperature. 
The laser beam was focused onto the sample with a 
Table 1 Properties of commercial carbon nanotubes as provided by suppliers
Sample Outer  
diameter  
(nm)
Inner  
diameter  
(nm)
Length  
(μm)
Ash  
content  
(wt%)
Purity  
(wt%)
Chemical  
impurities
Product Manufacturing  
method
SWNT 1 1–2 0.8–1.6 5–30 ,1.5 .90 0.08% Al 
0.41% Cl 
2.91% Co 
0.29% S
Cheaptubes  
SWNT 11
CCVD
SWNT 2 1.5 N/A 1–5 N/A .95 0% NanoLab PD15L15S  
(batch 43010)
CVD
SWNT 3 0.8–1.2 N/A 0.1–1 ,5 .93 ,5% Fe Unidym HiPco  
(batch SP10911)
CVD-HiPco
SWNT 4 1.2–1.7 N/A 0.1–4 ∼0.5 .95 0.23% Ni 
0.05% Y 
0.06% Fe
NanoIntegris PureTubes 
(batch P09-562)
Arc discharge
SWNT 5 1.2–1.7 N/A 0.1–4 ∼1 .95 0.07% Ni 
0.38% Y 
0.72% Fe 
5.39% I
NanoIntegris IsoNanotubes-M 
(batch M09-910)
Arc discharge
SWNT 6 1.2–1.7 N/A 0.1–4 ∼1 .95 0.07% Ni 
0.38% Y 
0.72% Fe 
5.39% I
NanoIntegris IsoNanotubes-S 
(batch S09-248)
Arc discharge
MWNT 1 8–15 3–5 10–50 ,1.5 .95 0.03% Al 
0.09% Cl 
0.12% S
Cheaptubes  
MWCNT15
CCVD
MWNT 2 20–30 5–10 10–30 ,1.5 .95 0.45% Cl 
0.26% Fe 
0.94% Ni
Cheaptubes  
MWCNT30
CCVD
MWNT 3 30–50 5–10 10–20 ,1.5 .95 0.21% Cl 
0.56% Fe 
1.87% Ni 
0.02% S
Cheaptubes  
MWCNT40
CCVD
MWNT 4 50–80 5–10 10–20 ,1.5 .95 0.21% Cl 
0.56% Fe 
1.88% Ni 
0.03% S
Cheaptubes  
MWCNT50
CCVD
MWNT 5 10–20 N/A 5–20 N/A .95 Fe, S NanoLab PD15L520 
(batch 41610)
CVD
MWNT 6 15–45 N/A 1–5 N/A .95 Fe, S NanoLab PD30L15  
(batch 40710)
CVD
MWNT 7 15–45 N/A 5–20 N/A .95 Fe, S NanoLab PD30L520 
(batch 60310)
CVD
MWNT 8 10–20 N/A 1–5 N/A .95 Fe, S NanoLab PD15L15  
(batch 181808)
CVD
MWNT 9 20–40 N/A 1–5 N/A .95 Fe, S NanoLab BPD30L15 
(batch 41410)
CVD
MWNT 10 20–40 N/A 5–20 N/A .95 Fe, S NanoLab BPD30L520 
(batch 81409)
CVD
MWNT 11 Manufactured in-house Nanotech Innovations 
(batch JP)
CCVD
MWNT 12 Manufactured in-house Nanotech Innovations 
(batch MI)
CCVD
Abbreviations: CCVD, catalytic chemical vapor deposition; CVD, chemical vapor deposition; N/A, not available; MWNT, multi-walled carbon nanotubes; SWNT, single-walled carbon 
nanotubes.
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20× objective and data were collected from 70–3700 cm-1 
at a power of 20 mW. All spectral analyses were performed 
using OPUS 6.0 software (Bruker Optics). Spectra were taken 
from three separate regions of the powder sample and overall 
average spectra were generated.
Preparation of CNT dispersions
Stock CNT solutions (approximately 0.05 mg/10 mL) were 
prepared using an XP6U ultra microbalance (sensitive to 
0.1 µg) equipped with a universal antistatic kit (Mettler 
Toledo, Toronto, ON, Canada). Approximately 1 mL of 
DCB was added to a vial containing the bulk CNT mate-
rial, followed by analytical transfer to a 20 mL scintillation 
vial, rinsing to ensure complete transfer of all the CNT 
material with a final volume of 8.5 mL. The CNT disper-
sion was sonicated in a bath sonicator for 500 minutes 
and fully dispersed CNT solutions were transferred to a 
10 mL volumetric flask and the volume was brought up to 
10 mL with DCB.
Ultraviolet-visible near infrared 
spectrophotometry
All absorption studies were performed using a SpectraMax 
ultraviolet-visible near infrared spectrophotometer (Molecular 
Devices, Sunnyvale, CA). Scans in the range of 200–1000 nm 
were collected every 10 nm. All DCB CNT samples were 
analyzed immediately after preparation using acrylic 
96-well plates (Corning Inc, Corning, NY) with a 200 µL 
sample volume. For analysis, measurements were taken at a 
500 nm wavelength with a 0.596 cm path length. For each 
of the 18 CNT samples, five independent CNT DCB stock 
solutions, were prepared according to the procedure described 
above. Standard curves composed of seven concentration 
points were generated for each independent stock solution. 
From each stock solution, three independent sets of standards 
were prepared, resulting in a standard curve representing the 
average absorption intensity of 15 measurements.
Statistical evaluation
Raw absorption data and average extinction coefficients were 
evaluated using one-way analysis of variance followed by a 
Tukey multiple comparison post-test statistical analysis (with 
a 95% confidence interval) using GraphPad Prism software 
(v 4; GraphPad Software Inc, San Diego, CA).
Results and discussion
Evaluating the effectiveness of CNT-based pharmaceutical 
formulations in treated cells or organisms requires the 
consideration of several parameters related to CNT 
concentration and dose. These include properties, such as 
CNT dimensions, surface topology, structural defects, and 
extent of impurities present in the samples. Often these 
pharmaceutically relevant specifications are provided by the 
manufacturer, but there is no standardized testing methodol-
ogy or requirement for the reporting of these values or relative 
interbatch consistency. We feel this lack of reporting is most 
obvious when addressing the determination of extinction 
coefficients for CNT materials, which are required for the 
calculation of accurate CNT concentrations in suspension.
The aim of this study was to characterize CNT materials 
employing standard analytical techniques that are generally 
accessible in most nanomaterial   laboratories. We subjected 
CNT materials to analysis by TGA, Raman spectroscopy, and 
ultraviolet-visible near infrared absorption spectroscopy in 
order to assess their quality as pharmaceutical excipients effi-
ciently and to compare our values with manufacturer specifi-
cations. Techniques such as TGA provide information about 
the amount of impurity and residual metal catalyst remaining 
in synthesized CNTs, which is very important when address-
ing toxicological considerations.21 While TGA can also pro-
vide information regarding coarse CNT structure,22 it must 
be evaluated in combination with additional data obtained 
from Raman spectroscopy. Raman spectroscopy itself is 
an indispensable technique for the qualitative and struc-
tural characterization (extent of defect sites) of CNTs 
and, most specifically, the determination of single-walled 
CNT   diameter.23 Finally, the determination of extinction 
  coefficients for each CNT material using ultraviolet-visible 
near infrared absorption spectroscopy provides a critical 
parameter for reliable CNT concentration determination.
To facilitate a rational selection of candidates from the 
large variety of commercially available single-walled CNT 
and multi-walled CNT materials, we defined four basic 
pharmaceutically applicable requirements, ie, #50 nm outer 
diameter,24 relatively narrow diameter distribution, #20 µm 
length,4,24–28 and 95% by weight structural purity (samples 
contained at least 95% CNTs by weight). Based on the fulfill-
ment of these four basic parameters, we purchased 16 CNT 
materials from several manufacturers (Table 1), and to evalu-
ate noncommercial sources, we synthesized two multi-walled 
CNT samples using a commercially available instrument.
Thermogravimetric analysis
TGA yields measurements of sample weight change as a 
function of temperature under a controlled atmosphere. 
In air, amorphous carbon burns at 200°C–400°C while CNTs 
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decompose at far higher temperatures, typically 800°C.22 
Compositional purity of CNT samples can be assessed by 
quantification of the residual mass (ash content) remaining 
after heating the samples to 800°C.21 Figure 1 illustrates 
combustion characteristics, ash content, and oxidation tem-
perature for each of the single-walled CNT and multi-walled 
CNT materials we examined. Of the total 18 CNT samples 
used for this study, single-walled CNT samples 5 and 6 
(NanoIntegris Isonanotubes-S and -M) were not subjected to 
TGA because the required sample size was cost prohibitive. 
Experimentally determined residual ash content for single-
walled CNT samples 1, 3, and 4 as well as multi-walled CNT 
samples 1–4 can be compared with those reported by the 
corresponding suppliers (Figure 1, gray columns). As shown, 
single-walled CNT sample 3 was found to have a slightly 
lower ash content than reported, while single-walled CNT 
samples 1 and 4 and multi-walled CNT samples 1–4 yielded 
a higher value than claimed by the suppliers. In general, it 
was found that 10 of the 16 samples had an ash content ≤ 5%. 
The residual masses for multi-walled CNT samples 12, 10, 
9, 8, and 5 (NanoLab) and single-walled CNT sample 1 
(CheapTubes) were clearly higher than previously reported. 
Of special concern was single-walled CNT sample 1, which 
demonstrated an exceedingly high difference between the 
manufacturers claimed ash content of less than 1.5% and 
our measured ash content of 38%. As produced, multi-walled 
CNT samples 11 and 12 (synthesized in-house) showed a high 
oxidation temperature indicative of a relatively low density 
of defect sites and 5%–7.5% ash content (Figure 1).
In all multi-walled CNT samples, an initial mass loss 
of approximately 5% at temperatures from 200°C to 400°C 
was observed (data not shown). This loss can be attributed 
to decomposition of polyaromatic fragments and amorphous 
carbon species, suggesting that the purity of most samples was 
$95%.   However, single-walled CNT samples 1–4 showed a 
higher mass loss (about 10%) before the nanotube oxidation 
temperature,   corresponding to a lower fraction of CNT and 
higher amorphous carbon content in the total carbon material 
(data not shown).
Ash content generally represents the amount of oxidized 
metal catalyst remaining in CNT samples following their 
synthesis. Metal content in CNTs is considered an impurity 
that can significantly affect the pharmacological properties of 
these nanomaterials, potentially resulting in undesired toxic 
effects. It is important to note that the manufacturer/supplier 
statements about CNT purity can be misleading because they 
sometimes refer only to overall carbonaceous content and not 
to the actual nanotube content of the material.
Multi-walled CNTs generally decompose at tempera-
tures higher than those for single-walled CNTs due to their 
multilayered structure.21 Accordingly, we observed higher 
oxidation temperatures for all multi-walled CNT samples. 
In-house characterization 800
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Figure 1 Ash content and oxidation temperature of carbon nanotubes. The ash content and oxidation temperature for four single-walled carbon nanotubes and twelve multi-
walled carbon nanotubes was experimentally determined using thermogravimetric analysis. Ash content is illustrated in the histogram, and oxidation temperature is in the scatter 
plot. Experimentally determined thermogravimetric analysis values (black bars or dots) are contrasted to the manufacturers’ reported values, where available (gray bars or dots). 
Abbreviations: SWNT, single-walled carbon nanotubes; MWNT, multi-walled carbon nanotubes.
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However, CNT oxidation temperature can also be affected 
by structural defects in the nanotube sidewalls. A higher 
density of defect sites suggests that the structural quality of 
multi-walled CNT samples 1–4 is higher as compared with 
multi-walled CNT samples 5, 6, 9, and 10, which had lower 
oxidation temperatures. This observation can be explained 
by manufacturer claims that the latter two samples are 
bamboo-like multi-walled CNTs for which a higher number 
of structural defects is expected. The influence of the struc-
tural composition in the nanotube material on the oxidation 
temperature is also evident in the observation of higher 
than expected oxidation temperatures for single-walled 
CNT samples 4–6 (NanoIntegris materials, Figure 1) which 
may be a result of their high levels of purity and crystalline 
structure, as suggested by a very low ID/IG ratio in the Raman 
analysis (Figure 2).29
raman spectroscopy
Raman spectroscopy is a common technique for the quali-
tative characterization of CNT structural parameters, par-
ticularly of single-walled CNTs. Raman spectroscopy can 
provide detailed information regarding both the purity of 
a CNT sample as well as structural information, including 
diameter distribution, electronic structure, and chirality of 
a single-walled CNT sample.23 Several scattering modes 
dominate the Raman spectrum of CNTs. These modes include 
the radial breathing mode (RBM) in the low wavenumber 
range (about 100–300 cm-1), which results from low-energy 
radial vibrations of carbon atoms in the nanotube lattice,30 
where all the carbon atoms are moving in-phase out of plane 
in the radial direction, the G-mode (about 1600 cm-1), a 
tangential vibrational mode characteristic to all graphitic 
materials, neighboring atoms move in opposite directions 
along the surface of the tube as in two dimensional graphite, 
the dispersive disorder-induced D-band (at wavenumbers 
below the G-mode) indicating the presence of defective 
sites in the single-walled CNT lattice, where C–C bonds are 
sp3-hybridized instead of the regular sp2 hybridization, and the 
G′-mode (at wavenumbers above the G-mode), representing 
a second-order related harmonic of the D-mode.31
Unfortunately, many of the characteristic properties that 
are present in the Raman spectra of single-walled CNTs are 
not as evident when studying multi-walled CNTs. As a result 
of the ensemble average over all inner tube diameters, the 
Raman signals are generally broadened and the RBM signal 
from large diameter multi-walled CNTs is usually too weak to 
be observed.31 For these samples, high resolution microscopic 
methods, such as transmission electron microscopy or atomic 
force microscopy, must be employed to obtain information 
about CNT diameters.
Raman spectra of CNT powders were used to evaluate 
the dimensions and structural purity of CNTs (Figure 2). 
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These spectra represent averaged data from 18 different dry 
CNT powders, obtained from excitation at a 532 nm laser 
wavelength. The spectra of single-walled CNT samples 
consistently demonstrated a much higher Raman intensity 
as compared with multi-walled CNT samples. The highest 
Raman intensities as well as lowest noise and sharpest features 
are observed for NanoIntegris samples (single-walled CNT 
samples 4–6) indicative of high nanotube quality and purity. 
Of notable exception, single-walled CNT sample 1 exhibited 
a very low overall Raman intensity and the spectral features 
compare more with those of the multi-walled CNT samples. 
This result suggests that this sample also contained a high frac-
tion of multi-walled CNTs, which agrees with our observation 
of lower structural purity from the TGA analysis (Figure 1).
Structural quality
The intensity ratio of the Raman D-band to G-band is often used 
to estimate the density of structural defects in CNTs, providing 
a relative measure for the structural quality of a sample.21,32 If 
both of these bands are similar in intensity, the density of struc-
tural defects is assumed to be high. Figure 3 illustrates the band 
intensity ID/IG ratios for all CNT samples, where a lower ratio 
indicates fewer defects and therefore higher structural quality. 
We observed the highest structural quality in single-walled CNT 
samples 4, 5, and 6, all of which were obtained from NanoInte-
gris. We consistently observed a considerably higher ID/IG ratio 
for all purchased multi-walled CNTs, which is indicative of a 
greater number of structural defects, most likely resulting from 
their growth in multiple graphite layers, whereas the in-house 
produced multi-walled CNT samples 11 and 12 had the low-
est ID/IG ratio of all the multi-walled CNT samples, indicating 
generally higher structural quality. As   previously observed in 
the TGA (Figure 1) and Raman (Figure 2) data, single-walled 
CNT sample 1 exhibited a considerably higher defect density 
than any of the other single-walled CNT samples, leading to 
the conclusion that single-walled CNT sample 1 contains a 
higher fraction of multi-walled CNTs. For the bamboo-like 
multi-walled CNT samples 9 and 10, we expected a high num-
ber of surface defects due to the particular structure of these 
nanotubes, which is confirmed by their high ID/IG ratio and 
slightly lower oxidation temperatures in TGA measurements. 
In all of the other CNT samples we examined, similar ID/IG ratio 
correlations are not as evident.
Diameter estimation of single-walled CNT samples
Within the characteristic Raman modes of single-walled 
CNTs, the RBM is of special interest, because the   frequency 
ϖRBM at which the radial vibrations of the C–C bonds 
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occur are strongly correlated with the tube diameter, dt, 
with ϖRBM = C1/dt + C2.31 The constants, C1 and C2, have 
to be determined experimentally because they depend on 
the synthesis process and aggregation state of individual 
single-walled CNTs.31,33 Values reported in literature for the 
parameter C1 vary among experiments, and any independent 
confirmation for values of C2 are lacking.34 Using the most 
pronounced RBM-related peaks in the single-walled CNT 
spectra, we have calculated the diameters of the single-walled 
CNTs for 15 different pairs of C1 and C2. The respective 
average diameter for each single-walled CNT sample is listed 
in Table 2 and is compared with the diameter reported by the 
suppliers. In addition to the C1 and C2 parameters obtained in 
our results, we also used the commonly adopted parameters 
for C1 = 223.5 cm-1 ⋅ nm and C2 = 12.5 cm-1, which have 
previously been reported for HiPco single-walled CNTs.35 
In our analysis, we found that the calculated average diam-
eter values for each of the CNT samples corresponded well 
with the dimensions reported by suppliers. Furthermore, 
using different sets of parameters for C1/C2 to calculate the 
diameters from the observed RBM peaks did not significantly 
affect our results.
Because Raman scattering in CNTs is a resonant process, 
only those CNTs for which one of the bandgaps is equal to 
the energy of the excitation laser contribute to the RBM in a 
spectrum.36 Since all known synthesis routes yield a range of 
electronic types31,33 that are distributed around a mean tube 
diameter,24 the excitation wavelength must be varied to obtain 
a full picture of all single-walled CNT diameters present in 
a sample.36 It is also well established that the bundling and 
aggregation of CNTs will result in shifted peak positions. 
Thus, the determination of single-walled CNT diameters 
from Raman spectra is afflicted with inaccuracies when not 
performed on well dispersed single-walled CNT suspensions. 
Consequently, results obtained from the dried CNT powders 
should be considered a first estimate of the dimensions of 
nanotubes present in an unknown sample and are only used 
to compare with manufacturer specifications.
Ultraviolet-visible near infrared 
absorption spectroscopy and standard 
CNT curves
Ultraviolet-visible near infrared spectroscopy is a standard 
analytical technique to determine the presence and concen-
tration of a material in solution. Using Beer–Lambert’s law 
(A = ε ⋅ c ⋅ l) and a calibration curve generated with known 
concentrations (c), the extinction coefficient (ε) can be 
determined from the slope of the curve, and a known path 
length (l).
Dispersion in DCB
As a consequence of the hydrophobic nature of graphene 
sidewalls and the strong π-π interactions between individual 
tubes, pristine CNTs have a strong tendency to aggregate and 
are practically insoluble in most solvents. Using CNTs for 
pharmaceutical applications raises a concern with regards 
to proper dispersion, and consequently accurate determina-
tion of concentration. Therefore, ultraviolet-visible near 
infrared absorbance will be highest only for maximally 
exfoliated CNTs.37 If dispersed CNTs reaggregate over the 
course of an experiment, absorbance values will gradually 
decrease affecting the accuracy of the experiment. It has 
previously been demonstrated that single-walled CNTs show 
the highest solubility in organic solvents such as DCB, and 
in order to maximize dispersability of CNTs, we chose this 
solvent for our ultraviolet-visible near infrared absorption 
experiments.38
We have used a specific strategy to obtain well dispersed 
CNTs in the organic solvent DCB, avoiding reaggregation 
and ensuring proper determination of absorbance values. 
In order to achieve a CNT concentration in DCB below the 
solubility limit in our stock solution, a very small amount of 
Table 2 Comparison of SWNT diameters as reported by manufacturer and determined experimentally through raman spectroscopy
CNT sample Reported  
diameter (nm)
ϖRBM (cm-1) Overall average diameter (nm)  
using different published  
parameters for C1 and C2
28
Determined  
diameter (nm) with 
C1 = 223.5 cm-1 ⋅ nm,   
C2 = 12.5 cm-1
SWNT 1 1–2 154.17 1.55 ± 0.13 1.58
SWNT 2 1.5 139.51 1.72 ± 0.15 1.76
SWNT 3 0.8–1.2 272.49 0.87 ± 0.06 0.86
SWNT 4 1.2–1.7 167.37 1.43 ± 0.12 1.44
SWNT 5 1.2–1.7 171.16 1.39 ± 0.11 1.41
SWNT 6 1.2–1.7 156.12 1.53 ± 0.13 1.56
Abbreviations: CNT, carbon nanotube; SWNT, single-walled carbon nanotubes; ϖRBM, frequency of radial vibrations; C1, C2, constants for ϖRBM = C1/dt + C2.25
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approximately 50 µg CNT material was used for dispersion. 
The stock CNT DCB solutions had a final concentration of 
approximately 0.05 mg/10 mL and were sonicated in a bath 
sonicator while monitoring the absorption at a wavelength 
of 500 nm. Using this method, an optimal sonication time 
of 8 hours was established, which ensured that a maximum 
ultraviolet-visible near infrared absorbance value was 
measured.
Extinction coefficients of CNTs in DCB
From each of the stock CNT solutions, seven independent 
standards were prepared in triplicate and measured using a 
96-well plate. Figure 4 shows the average standard curves for 
all of the 18 CNT samples. Each of the seven data points in 
these standard curves represents an average of 15   independent 
measurements and shows linearity, with R2 values between 
0.9902 and 0.9999. Table 3 lists the average extinction coef-
ficients for single-walled CNTs and multi-walled CNTs, 
which range between 24.9 and 54.2 mL·cm-1·mg-1 and 49.0 
and 68.3 mL·cm-1·mg-1, respectively.
We hypothesized that experimentally determined extinc-
tion coefficients can differ greatly between different types of 
CNTs (single-walled CNTs vs multi-walled CNTs), CNTs 
with different physical properties (outer diameter, length, and 
purity) and CNTs synthesized using various manufacturing 
methods. This hypothesis was confirmed when we calculated 
the statistical deviation in the measured extinction coefficients 
for all of the CNT samples. Extinction coefficients for single-
walled CNT samples 1 and 2 were significantly different from 
all other single-walled CNTs (P , 0.05) and multi-walled 
CNTs (P , 0.001), but were not significantly different from 
each other. The extinction coefficient for single-walled CNT 
sample 3 (HiPco) was different from most of the multi-walled 
CNT samples (3, 4, 6, 7, 8, and 9, P , 0.01). Among the 
multi-walled CNTs, sample 1 was significantly different from 
multi-walled CNT samples 4, 5, 6, and 8, while multi-walled 
CNT sample 6 differed significantly from all six single-walled 
CNTs and nine of the MWNTs (P , 0.05). Interestingly, we 
observed that the extinction coefficient for NanoLab multi-
walled CNT sample 6 was significantly different when com-
pared with multi-walled CNT sample 2, which had a similar 
diameter of 30 nm (P , 0.001), but did not show significant 
differences when compared with multi-walled CNT samples 
3 and 4 (Cheaptubes, diameters 30–80 nm). Other significant 
differences in the extinction coefficients included multi-walled 
CNT sample 1 when compared with multi-walled CNT 
samples 4 and 8 (P , 0.05), and multi-walled CNT sample 
5 versus multi-walled CNT sample 8 (P , 0.05), which are 
from the same manufacturer, and have the same reported 
outer diameter.
The results presented in Figure 4 also clearly demonstrate 
that absorbance values can differ significantly when compar-
ing single-walled CNTs with multi-walled CNTs and when 
comparing different manufacturing sources of the same types 
of CNTs. Statistical analysis indicated that absorbance values 
for single-walled CNT samples 1 and 2 were significantly dif-
ferent from the other single-walled CNT samples (P , 0.001) 
and all other multi-walled CNT samples (P , 0.01). The 
difference between the 12 multi-walled CNT samples was 
not significant (P . 0.05) within the full concentration range, 
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but at the higher concentrations (5 µg/mL), multi-walled CNT 
samples 5, 6, and 8 showed differences from the other multi-
walled CNTs. This could indicate that during preparation of 
the higher concentration samples, taking larger volumes from 
the original stock solutions can introduce increased error if the 
sample is not completely homogeneous. This further implies 
that when analyzing unknown CNT samples these types of 
transfer errors can lead to an overestimation or underestima-
tion of CNT concentrations by up to 30%–40%. This is illus-
trated by the standard curves presented in Figure 5A and B for 
two representative samples, ie, multi-walled CNT samples 2 
and 3, which have similar specifications for synthetic method 
and purification and are from the same manufacturer (Cheap-
tubes). The relative standard deviation on precision (repeat-
ability) for the full concentration range in multi-walled CNT 
sample 2 is ,3.5%, whereas in multi-walled CNT sample 
3 it is ,11.4%. According to TGA analysis (Figure 1) and 
Raman spectra (Figure 2), both samples are equal in purity 
and structural quality. However, while multi-walled CNT 
sample 2 emerges as a rather homogenous material with an 
average extinction coefficient of 51.4 ± 2.9 mL·cm-1·mg-1 
relating to a percentage deviation of 5.6%, multi-walled 
CNT sample 3 with a similar extinction coefficient of 
58.0 ± 7.3 mL·cm-1·mg-1 shows higher heterogeneity with 
12.6% deviation. The coefficient of variation values for the 
average extinction coefficients in Table 3 (ranging between 
4% and 18%) are partly an indication of the variability in 
sampling due to heterogeneity within each CNT material. The 
heterogeneity of each CNT sample is important when con-
sidering the pharmaceutical quality of a CNT sample. Once 
acceptable limits have been established, some CNT samples 
would have to be rated unsuitable because the material may 
be too heterogeneous for proper evaluation.
Variability in ultraviolet-visible near infrared absor-
bance and hence the experimental extinction coefficient, 
can also originate from different structural compositions, 
physicochemical properties, and impurities in the final CNT 
material. These differences are a consequence of synthesis 
procedures and purification methods. Looking closer at the 
NanoIntegris single-walled CNTs, samples 4 (Puretubes), 
5 (Isonanotubes-M), and 6 (Isonanotubes-S), we can observe 
a slight but clear influence of electronic type on the extinc-
tion coefficient (Figure 6). Depending on the chiral vector, a 
single-walled CNT can be either metallic or semiconducting, 
and as a consequence, a single-walled CNT sample normally 
consists of approximately one-third metallic and two-thirds 
semiconducting nanotubes.39 Single-walled CNT samples 5 
and 6 are purified CNTs according to their electronic type, 
with the former being metallic and the latter semiconduct-
ing single-walled CNTs. Single-walled CNT sample 4 is the 
nanotube material prior to separation according to these two 
electronic types. The ratio of 1:2 of metallic to semiconduct-
ing single-walled CNTs in single-walled CNT sample 4 is 
well reflected in the standard curves presented in Figure 6. 
The standard curve of single-walled CNT sample 4 is 
an exact superposition of the standard curves of single-
walled CNT samples 5 and 6 in a ratio of 1:2, respectively. 
  Correspondingly, the average extinction coefficients (Table 3) 
of single-walled CNT sample 4 can be obtained by simple 
weighed addition of single-walled CNT samples 5 and 6 with 
51.7 mL·cm-1·mg-1 ⋅ 1/3 + 54.2 mL·cm-1·mg-1 ⋅ 2/3 equals to 
53.4 mL·cm-1·mg-1 (with the experimental value for single-
walled CNT sample 4 being 53.1 ± 2.9mL·cm-1·mg-1).
When attempting to compare extinction coefficients deter-
mined here with those found in the literature, we discovered 
Table 3 Average extinction coefficients (εave, with corresponding 
variation) of carbon nanotubes in 1,2-dichlorobenzene
Sample εave ± SD (n = 5)  
(mL ⋅ cm-1 ⋅ mg-1)
CV%
SWNT 1 24.9 ± 4.5 18.1
SWNT 2 30.5 ± 2.3 7.5
SWNT 3 43.8 ± 3.1 7.1
SWNT 4 53.1 ± 2.9 5.5
SWTN 5 51.7 ± 6.6 12.8
SWTN 6 54.2 ± 3.1 5.7
MWNT 1 49.0 ± 5.8 11.8
MWNT 2 51.4 ± 2.9 5.6
MWNT 3 58.0 ± 7.3 12.6
MWNT 4 60.9 ± 8.4 13.8
MWNT 5 49.4 ± 3.2 6.5
MWNT 6 68.3 ± 2.8 4.1
MWNT 7 56.3 ± 3.9 6.9
MWNT 8 61.3 ± 6.9 11.3
MWNT 9 56.1 ± 5.6 10.0
MWNT 10 53.5 ± 6.4 12.0
MWNT 11 55.3 ± 5.8 10.5
MWNT 12 53.0 ± 4.1 7.7
Notes: Using the Beer–Lambert Law A = ε ⋅ c ⋅ l, where ultraviolet-visible absorbance 
at 500 nm (A500) was experimentally determined, concentration (c) represents the 
stock solution concentrations used in the standard curves, and pathlength (l) was 0.596 
cm. [Statistical analysis was performed by one-way analysis of variance followed by a 
Tukey multiple comparison post-test, significant results: SWNT 1 versus SWNT 3–6 
(P , 0.001) and versus MWNT 1–12 (P , 0.001); SWNT 2 versus SWNT 3–6 (P , 
0.05) and versus MWNT 1–12 (P , 0.001); SWNT 3 versus MWNT 3, 4, and 6–9 
(P , 0.05); MWNT 6 versus SWNT 1–6 (P , 0.01) and versus MWNT 1, 2, 5, and 
7–12 (P , 0.05); MWNT 1 versus MWNT 4 and 8 (P , 0.05), MWNT 5 versus 
MWNT 8 (P , 0.05)].
Abbreviations: CV, coefficient of variation; MWNT, multi-walled carbon nanotubes; 
SWNT, single-walled carbon nanotubes; SD, standard deviation.
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that there is a general misconception regarding the validity 
of previously calculated values, and many research groups 
incorrectly apply these extinction coefficients to their specific 
nanotube system. For example, the extinction coefficient for 
HiPco single-walled CNT in DCB was calculated by Bahr 
et al to be 28.6 mL·cm-1·mg-1 at 500 nm,38 as compared with 
our experimentally determined value of 43.8 mL·cm-1·mg-1 for 
single-walled CNTs also produced by the HiPco method but by 
a different manufacturer. The extinction coefficient value pub-
lished by Bahr et al38 was subsequently used by three different 
groups to analyze single-walled CNT dispersions in micelles,40 
single-walled CNTs in aqueous solutions,41 and multi-walled 
CNTs dispersed in surfactants.42 Since the different diameter, 
purity, chirality type, and solvent effects may alter the value 
of the extinction coefficient significantly, this value must be 
determined for each CNT material exclusively.
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Conclusion
In this study, TGA, Raman spectroscopy, and ultraviolet-
visible near infrared absorbance spectroscopy were used to 
characterize and compare sixteen different commercially 
available and two noncommercial CNT materials. Our aim 
was to assess the level of purity and quality of these materials 
for potential incorporation in pharmaceutical formulations. 
Of particular interest, we determined extinction coefficients 
for single-walled CNT and multi-walled CNT dispersions in 
DCB as a standard solvent.
In summary, we found that each CNT raw material requires 
a thorough pharmaceutical workup to be valid and accurate 
before it can be used in in vitro or in vivo   experiments. 
Ultraviolet-visible near infrared absorbance analysis identi-
fied a significant variation in extinction coefficients depend-
ing on the source, CNT type, single-walled CNT electronic 
type, and manufacturing process. These results clearly 
demonstrated that there is no one single extinction coefficient 
that can be universally applied to all types of CNTs, and it is 
critical to use the appropriate extinction coefficient for each 
CNT material to ensure reliable concentration determination. 
Furthermore, we also observed that some CNT materials 
exhibited considerable inhomogeneities, resulting in signifi-
cant variations in the extinction coefficients calculated from 
the same CNT batch.
Because CNTs from different sources can be synthesized 
using a variety of techniques, all of which are known to yield 
fairly inhomogeneous materials that contain many impuri-
ties, their characterization proves to be a persistent hurdle in 
the identification and selection of approved standards. It is 
worth mentioning that, for now, most efforts are dedicated to 
single-walled CNT standards, and the first National Institute 
of Standards and Technology (NIST)-certified single-walled 
CNT material is anticipated to be available at the earliest in 
2012 (B Simard, personal communication). Several organiza-
tions such as NIST43 and the International Organization for 
Standardization,12 as well as other research groups,44 have been 
working on the development of a compendium of standard-
ized measurements and protocols for the characterization of 
single-walled CNTs and multi-walled CNTs. In addition to 
the analytical techniques presented here, the recommended 
techniques for CNT characterization also include transmission 
electron microscopy, scanning electron microscopy, energy-
dispersive X-ray analysis, near infrared photoluminescence 
spectroscopy, evolved gas analysis–gas chromatography–mass 
spectrometry, measurement of moisture content, ash content, 
metallic constituents, volatile content, polyaromatic hydro-
carbon content, and carbon materials.12
While time-consuming, rigorous physicochemical 
characterization is necessary to obtain well defined CNTs, 
especially in the scope of biomedical and pharmaceutical 
applications. The quality of CNT materials used in experi-
ments to assess their effects in biological systems is clearly 
important. The specific degree of chemical and defined 
structural purity needs to be considered carefully to obtain 
relevant results. The knowledge of accurate concentration 
values is essential to reproducible dosing and measurement 
of observed effects. The overall level of accuracy needed for 
all physicochemical parameters mentioned will depend on 
the width of an excipient’s function-toxicity window. This 
is a concept similar to a drug-therapeutic window, which 
defines the concentration range for an active ingredient that 
is expected to be clinically effective without unwanted side 
effects. There is an urgent need for the definition of standard-
ized guidelines for pharmaceutical grade CNTs, to encourage 
and enable manufacturers to offer high quality CNT materials 
that are suitable for incorporation in pharmaceuticals and 
other medicinal products.
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